Velocity Clinical Research, Inc.

Velocity Clinical Research, Inc. is a leading biotechnology research organization dedicated to advancing human health through high-quality clinical trials. With a strong focus on delivering exceptional data and patient care, Velocity Clinical Research, Inc. collaborates with pharmaceutical and biotechnology companies to accelerate the development of new drugs, medical devices, diagnostics, and combination products.

Headquartered at 300 E Main St, Durham, North Carolina 27701, US, Velocity Clinical Research, Inc. operates a global network of fully integrated clinical research sites. The company's unified research site solutions ensure the right patients, investigators, and research staff are available for clinical trials across the U.S. and Europe. Velocity Clinical Research, Inc. also leverages innovative technology to streamline operations and enhance data-driven decision-making.

Velocity Clinical Research, Inc. is committed to improving clinical research through efficiency, innovation, and a patient-centric approach. To discover how Velocity Clinical Research, Inc. delivers high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale, please visit VelocityClinical.com. We invite the company’s management to create a customized and exclusive company showcase and product listing on our platform.